AbbVie
ABBV
#30
Rank
$296.45 B
Marketcap
$167.76
Share price
0.71%
Change (1 day)
21.29%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2024 : $6.07 Billion USD

According to AbbVie's latest financial reports the company has $6.07 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$10.39 B-39.86%
2022-12-31$$17.28 B11.99%
2021-12-31$$15.43 B17.86%
2020-12-31$$13.09 B-260.27%
2019-12-31$-$8.18 Billion-3.24%
2018-12-31$-$8.45 Billion-265.71%
2017-12-31$$5.09 B9.94%
2016-12-31$$4.63 B17.52%
2015-12-31$$3.94 B126.46%
2014-12-31$$1.74 B-61.22%
2013-12-31$$4.49 B33.57%
2012-12-31$$3.36 B-71.82%
2011-12-31$$11.93 B-24.01%
2010-12-31$$15.70 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$92.55 B 1,424.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$17.20 B 183.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.32 B 135.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.52 B 23.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.19 B 199.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.35 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.00 B 196.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
$39.59 B 552.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.71 B-55.21%๐Ÿ‡บ๐Ÿ‡ธ USA